Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial.
about
Sex hormone-binding globulin and risk of type 2 diabetes in women and menEstrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.Metabolic disorders in menopauseVascular disease in diabetic women: Why do they miss the female protection?Prescribing menopausal hormone therapy: an evidence-based approachEstrogen: an emerging regulator of insulin action and mitochondrial functionHRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRTInsulinotropic effect of the non-steroidal compound STX in pancreatic β-cellsEstrogenic plant extracts reverse weight gain and fat accumulation without causing mammary gland or uterine proliferationMenopause, hormone therapy and diabetes.Efficacy of Osteoporosis Therapies in Diabetic Patients.Exploration of the utility of ancestry informative markers for genetic association studies of African Americans with type 2 diabetes and end stage renal disease.Comprehensive evaluation of the estrogen receptor alpha gene reveals further evidence for association with type 2 diabetes enriched for nephropathy in an African American populationThe metabolic syndrome2-Methoxyestradiol ameliorates glucose tolerance with the increase in β-cell mass in db/db mice.Risk factors of type 2 diabetes among Korean adults: The 2001 Korean national health and nutrition examination survey.Estrogen: a master regulator of bioenergetic systems in the brain and bodyMinireview: Estrogenic protection of beta-cell failure in metabolic diseases.Gender differences in insulin resistance, body composition, and energy balance.Bone and glucose metabolism: a two-way streetThe 2012 hormone therapy position statement of: The North American Menopause Society.Improvements of insulin resistance in ovariectomized rats by a novel phytoestrogen from Curcuma comosa Roxb.Longitudinal study of insulin resistance and sex hormones over the menstrual cycle: the BioCycle Study.Factors associated with beta-cell dysfunction in type 2 diabetes: the BETADECLINE study.Postmenopausal hormone therapy and the risks of coronary heart disease, breast cancer, and stroke.Progestins and progesterone in hormone replacement therapy and the risk of breast cancer.Estradiol regulates insulin signaling and inflammation in adipose tissue.17ß-estradiol antagonizes the down-regulation of ERα/NOS-3 signaling in vascular endothelial dysfunction of female diabetic ratsMenopause care for obese and diabetic women.Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative.Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in miceAltered estrogen receptor expression in skeletal muscle and adipose tissue of female rats fed a high-fat dietCoronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women's Health Initiative randomized clinical trials.Heterogeneity of genetic associations of CDKAL1 and HHEX with susceptibility of type 2 diabetes mellitus by gender.Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents β cell failure in rodent models of type 2 diabetes.Estrogens and the diabetic kidneyEffect of targeted estrogen delivery using glucagon-like peptide-1 on insulin secretion, insulin sensitivity and glucose homeostasis.Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale de l'Education Nationale (E3N) cohort.From in vivo gene targeting of oestrogen receptors to optimization of their modulation in menopause.Insulin resistance with hormone replacement therapy: associations with markers of inflammation and adiposity
P2860
Q24643947-070A1B7D-01F5-4CD1-A974-33A1AAA2636EQ24658109-D8DAA259-35C7-4576-8F05-21AB7ACA9E38Q26795571-ACFCAB53-170D-4060-B34F-85652ACA4092Q27011447-7B6FC94A-CAA7-4638-B6E8-8DD862E64827Q27022920-9F86A11B-DA8C-4DCA-9C63-3C065B393E46Q28085599-25E47270-514E-46DA-8803-E62C98895BF1Q28294446-9FADA051-0252-493B-AB98-FF2B782E6E26Q28482218-9AF0DC0D-13B9-467C-92DB-BEAF9505EE5BQ28741749-90333AF2-B377-4FB0-A601-F8D15B7E938FQ30239769-E4A20580-0835-4E85-A141-7CB8FD00E7A4Q30248776-4E4B7716-579F-45BB-991F-28A8E9035AE1Q30437685-4AFBC9BF-B7D0-4E7C-90EE-DFD8F07D63AAQ30438435-05B5DE7B-9B0F-4514-B6B3-4D0819693EF7Q33569142-F90B14AA-0144-4D36-875B-B30F3DC6C275Q33585615-4AD1E141-2448-4A2E-B073-87863E8767AAQ33601989-02FF59AE-59BF-46F5-887A-C0583C9F62D6Q33623924-ED5762F8-9E6E-49C8-9054-6D8B28FD96C2Q33735534-65AC5B17-B13C-497F-B3CF-24AE04CF0320Q34013754-06CD5787-9890-45B3-A373-20B626297030Q34160465-2B62203A-6778-4BB6-BB58-96462A15DF0FQ34161400-9D299574-82CD-44B6-889B-68D02355F606Q34215079-CF4347D4-B3EA-477E-B97B-01F4E13E5D2AQ34395402-AC4C54CB-CF57-4406-B435-B8CE30254617Q34407830-0E6B1B8E-18BC-4480-89EB-30D25C7DE4D2Q34420014-B67C6079-C2C6-459F-BFE4-AA92106F2DB5Q34420425-F52727A1-E602-4AE2-85DA-318FC6B78BCAQ34460666-AA52E082-DC0A-48BD-A499-4F4B472BA032Q34500262-35342A83-4E26-4CF2-8818-176ACAC1A847Q34608171-EF68A2CB-DB84-4CCD-A937-BEF617AE620DQ34611511-12912402-BA44-4AC7-8CB2-EDE78768D558Q34694998-F6FB2C7E-1130-4361-B90F-237426A9D0E5Q34785060-263B15B8-A325-4566-B25D-8A25559D151BQ34788703-B65C8BBC-14B8-4FB8-BFE3-C512CB701631Q35031022-F708E6A6-DA36-484C-9B3B-AE2E433F12C8Q35142822-124FBB99-29AA-4229-8581-47A38CE6B3BCQ35228627-F4F6B68D-B65D-4D57-8C76-11B373344429Q35599917-391A62E3-527D-4F98-93B5-0DA19428CAAEQ35618612-0BB0C35E-BACA-490A-ACCF-39E3B13E376AQ35657905-31057826-2F58-496B-A1DF-D77965B893F3Q35728222-22BBF7BB-5EA0-46BB-B399-2095682CAA45
P2860
Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Effect of oestrogen plus proge ...... alth Initiative Hormone Trial.
@en
type
label
Effect of oestrogen plus proge ...... alth Initiative Hormone Trial.
@en
prefLabel
Effect of oestrogen plus proge ...... alth Initiative Hormone Trial.
@en
P2093
P2860
P1433
P1476
Effect of oestrogen plus proge ...... ealth Initiative Hormone Trial
@en
P2093
B V Howard
L S Phillips
R J Rodabough
T Bassford
Women’s Health Initiative Investigators
P2860
P2888
P304
P356
10.1007/S00125-004-1448-X
P577
2004-07-14T00:00:00Z